Correlation between age and MMSE in schizophrenia

Jean-Robert Maltais1, Geneviève Gagnon2, Marie-Pierre Garant3

  • 1Centre de Santé et de Services Sociaux,Institut Universitaire de Gériatrie de Sherbrooke,University of Sherbrooke,Quebec,Canada.

Abstract

Insights

Mini-Mental State Examination (MMSE) scores in schizophrenia patients decline five times faster than in the general population. This decline is significantly more pronounced in institutionalized patients compared to community-dwelling individuals.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Gerontology

Background:

  • The Mini-Mental State Examination (MMSE) is a common cognitive screening tool used in schizophrenia research.
  • Normative MMSE data for the schizophrenia population are limited.
  • Aging effects on cognitive function in schizophrenia require further investigation.

Purpose of the Study:

  • To analyze the impact of aging on Mini-Mental State Examination (MMSE) scores in patients with schizophrenia.
  • To compare the rate of cognitive decline due to aging between institutionalized and community-dwelling schizophrenia patients.

Main Methods:

  • A systematic literature search was conducted using PubMed and PsychInfo with keywords 'schizophrenia' and 'MMSE'.
  • Included studies provided MMSE scores and mean age for schizophrenia patients.
  • A weighted linear regression analysis was performed, with weights inversely proportional to the variance of the age variable.

Main Results:

  • A meta-regression analysis of 56 articles (5,588 patients) revealed that MMSE scores in schizophrenia patients decline by approximately 1 point every four years.
  • This rate of decline is five times greater than that observed in the general population.
  • Institutionalized patients showed a significant decline in MMSE scores with age (R² = 0.622), while community-dwelling patients exhibited relatively stable scores (R² = 0.037).

Conclusions:

  • Significant differences in age-related cognitive trajectories exist between institutionalized and community-dwelling schizophrenia patients.
  • Factors such as illness severity, medication, vascular risks, and environmental stimulation may contribute to cognitive decline in institutionalized patients.
  • Further research on executive functions and the impact of specific variables is recommended for a comprehensive understanding of cognitive aging in schizophrenia.